Published in Eur J Pharmacol on April 02, 2010
New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry (2011) 2.11
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav (2011) 1.38
Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology (2010) 1.25
Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. Nat Neurosci (2013) 1.22
Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors. J Neurophysiol (2011) 1.14
mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci (2011) 1.10
Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving. Neuropharmacology (2013) 1.10
Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1. Mol Pain (2010) 1.02
Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav (2011) 1.00
Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules (2011) 0.99
mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making. J Neurophysiol (2011) 0.97
Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche. Curr Opin Neurobiol (2013) 0.96
AMPA Receptor Plasticity in Accumbens Core Contributes to Incubation of Methamphetamine Craving. Biol Psychiatry (2016) 0.95
Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Bioorg Med Chem Lett (2015) 0.92
Estradiol mediates dendritic spine plasticity in the nucleus accumbens core through activation of mGluR5. Brain Struct Funct (2014) 0.89
Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol (2014) 0.87
Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury. Neurotherapeutics (2014) 0.87
The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice. PLoS One (2013) 0.83
Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol (2014) 0.83
Functional regulation of PI3K-associated signaling in the accumbens by binge alcohol drinking in male but not female mice. Neuropharmacology (2016) 0.80
NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals (Basel) (2013) 0.77
Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology (Berl) (2010) 0.77
Group III metabotropic glutamate receptors and drug addiction. Front Med (2013) 0.77
mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex. CNS Neurol Disord Drug Targets (2015) 0.77
Prolonged Induction of miR-212/132 and REST Expression in Rat Striatum Following Cocaine Self-Administration. Mol Neurobiol (2016) 0.77
The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues. Br J Pharmacol (2016) 0.76
Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function. J Neurochem (2015) 0.75
PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging (2011) 0.75
Hurdles in Basic Science Translation. Front Pharmacol (2017) 0.75
Phosphorylation of group I metabotropic glutamate receptors in drug addiction and translational research. J Transl Neurosci (2016) 0.75
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Meta-analysis of cue-reactivity in addiction research. Addiction (1999) 10.43
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34
Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) (1999) 7.06
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov (2009) 6.69
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Applying extinction research and theory to cue-exposure addiction treatments. Addiction (2002) 5.47
Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse (2004) 5.44
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol (2010) 4.77
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science (2002) 3.91
Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology (2010) 3.81
The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci (2009) 3.79
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron (2005) 3.75
Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology (2007) 3.73
Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol (1998) 3.65
Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci (2006) 3.54
Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci (1997) 3.49
N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci (2009) 3.49
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci (2001) 3.41
The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology (2005) 3.28
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci (2008) 3.22
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci (2001) 3.09
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol (1998) 3.00
Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev (1999) 2.95
Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci (1997) 2.89
Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience (2006) 2.87
Switching from automatic to controlled action by monkey medial frontal cortex. Nat Neurosci (2007) 2.85
Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature (2005) 2.84
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther (2004) 2.83
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev (2009) 2.82
Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science (2007) 2.77
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet (2009) 2.76
Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci (2006) 2.73
Glutamate receptor function in learning and memory. Behav Brain Res (2003) 2.72
Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci (2004) 2.59
Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav (2009) 2.56
Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat Neurosci (2009) 2.50
Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem (2002) 2.50
Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol (2005) 2.47
Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo. J Med Chem (2004) 2.46
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther (2006) 2.44
Glutamate systems in cocaine addiction. Curr Opin Pharmacol (2004) 2.42
Prefrontal control of the amygdala. J Neurosci (2005) 2.39
Reconsolidation: maintaining memory relevance. Trends Neurosci (2009) 2.32
Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol (1995) 2.29
A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol (2003) 2.27
Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens. Nat Neurosci (2006) 2.23
A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. J Pharmacol Exp Ther (2004) 2.17
Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci (2005) 2.17
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11
Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett (1993) 2.10
Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J Pharmacol Exp Ther (2005) 2.08
Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction (2010) 2.04
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol (2008) 1.99
Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav (1992) 1.96
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol (2002) 1.95
Opioids block long-term potentiation of inhibitory synapses. Nature (2007) 1.94
The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci (2004) 1.90
Metabotropic glutamate receptors. Cell Tissue Res (2006) 1.89
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev (2006) 1.86
Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology (2006) 1.84
Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology (2008) 1.84
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) (2003) 1.83
Homer proteins regulate sensitivity to cocaine. Neuron (2004) 1.83
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology (2004) 1.83
Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem (2002) 1.82
A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol (2005) 1.82
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J Pharmacol Exp Ther (2008) 1.81
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology (2009) 1.80
Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem (2006) 1.77
G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci (1999) 1.76
Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol (1992) 1.76
mGluR5 has a critical role in inhibitory learning. J Neurosci (2009) 1.76
Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci (2005) 1.75
DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci (2007) 1.74
Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res (2009) 1.73
Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci (2000) 1.69
Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2007) 1.69
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) (2004) 1.69
Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev (2009) 1.66
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience (2001) 1.64
(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology (1997) 1.61
Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn Mem (1999) 1.59
mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology (2008) 1.57
Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. Eur J Pharmacol (2004) 1.52
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology (Berl) (2005) 1.51
The role of neuroadaptations in relapse to drug seeking. Nat Neurosci (2005) 1.51
The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology (Berl) (2004) 1.51
The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol (2004) 1.50
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) (2005) 1.49
Glutamatergic mechanisms in addiction. Mol Psychiatry (2003) 1.49